Dr Gemma Currie

  • Honorary Clinical Senior Lecturer (School of Cardiovascular & Metabolic Health)

email: Gemma.Currie@glasgow.ac.uk

Room 313, BHF Building, 126 University Avenue, Glasgow

Import to contacts

ORCID iDhttps://orcid.org/0000-0002-0797-0224

Publications

List by: Type | Date

Jump to: 2023 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012
Number of items: 35.

2023

Rotbain Curovic, V. et al. (2023) Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – a post-hoc analysis of the PRIORITY randomized clinical trial. Journal of Diabetes and its Complications, 37(4), 108433. (doi: 10.1016/j.jdiacomp.2023.108433) (PMID:36841085)

Setjiadi, D., Delles, C. , Currie, G. and Celis-Morales, C. A. (2023) Relationship between blood pressure level and hypertensive mediated organ damage. The 26th Annual Meeting of the Scottish Cardiovascular Forum, Aberdeen, UK, 04 Feb 2023. A2.1-A2. (doi: 10.1136/heartjnl-SCF-2023.4)

2022

Connelly, P. J. , Currie, G. and Delles, C. (2022) Sex differences in the prevalence, outcomes and management of hypertension. Current Hypertension Reports, 24(6), pp. 185-192. (doi: 10.1007/s11906-022-01183-8) (PMID:35254589) (PMCID:PMC9239955)

2020

Currie, G. , Mary, S. and Delles, C. (2020) Is there a role for proteomics in diabetic renal disease? NDT Plus, 35(7), pp. 1133-1135. (doi: 10.1093/ndt/gfz017) (PMID:32777079) (PMCID:PMC7417003)

Tofte, N. et al. (2020) Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial. Lancet Diabetes and Endocrinology, 8(4), pp. 301-312. (doi: 10.1016/S2213-8587(20)30026-7) (PMID:32135136)

Mary, S. , Currie, G. , Schutte, A. E. and Delles, C. (2020) Cardiovascular proteomics. In: Faintuch, J. and Faintuch, S. (eds.) Precision Medicine for Investigators, Practitioners and Providers. Academic Press: London ; San Diego, CA, pp. 263-270. ISBN 9780128191781 (doi: 10.1016/b978-0-12-819178-1.00025-3)

2019

Connelly, P. J. , Freel, E. M., Perry, C., Ewan, J., Touyz, R. M. , Currie, G. and Delles, C. (2019) Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults. Hypertension, 74(6), pp. 1266-1274. (doi: 10.1161/HYPERTENSIONAHA.119.13080) (PMID:31656099) (PMCID:PMC6887638)

Currie, G. and Delles, C. (2019) Vascular biomedicine in an era of chronic disease and multimorbidity. Clinical Science, 133(9), pp. 1137-1143. (doi: 10.1042/CS20180764) (PMID:31088896) (PMCID:PMC6522703)

Currie, G. and Nilsson, P. M. (2019) Healthy vascular ageing and early vascular ageing. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 307-318. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_29)

Ravassa, S., Delles, C. , Currie, G. and Díez, J. (2019) Biomarkers of cardiovascular disease. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 319-330. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_30)

Small, H. Y., Currie, G. and Delles, C. (2019) Endothelial dysfunction. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 183-192. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_17)

2018

Tofte, N. et al. (2018) Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes. Diabetic Medicine, 35(10), pp. 1375-1382. (doi: 10.1111/dme.13669) (PMID:29781558)

Siméon, S., Massy, Z., Højlund, K., Lalic, K., Porcellati, F., Dekker, J., Petrie, J. , Currie, G. and Balkau, B. (2018) Renal function markers and insulin sensitivity after 3 years in a healthy cohort, the EGIR-RISC study. BMC Nephrology, 19, 124. (doi: 10.1186/s12882-018-0918-1) (PMID:29855339) (PMCID:PMC5984396)

Currie, G. E. et al. (2018) Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria. Cardiovascular Diabetology, 17, 50. (doi: 10.1186/s12933-018-0697-9) (PMID:29625564) (PMCID:PMC5889591)

Delles, C. and Currie, G. (2018) Sex differences in hypertension and other cardiovascular diseases. Journal of Hypertension, 36(4), pp. 768-770. (doi: 10.1097/HJH.0000000000001655) (PMID:29489615) (PMCID:PMCID: PMC5856361)

Currie, G. and Delles, C. (2018) Blood pressure targets in the elderly. Journal of Hypertension, 36(2), pp. 234-236. (doi: 10.1097/HJH.0000000000001576)

2017

Currie, G. and Delles, C. (2017) Healthy vascular ageing. Hypertension, 70(2), pp. 229-231. (doi: 10.1161/HYPERTENSIONAHA.117.09122) (PMID:28559393)

Currie, G. , Bethel, M. A., Holzhauer, B., Haffner, S. M., Holman, R. R. and McMurray, J. J.V. (2017) Effect of valsartan on kidney outcomes in people with impaired glucose tolerance. Diabetes, Obesity and Metabolism, 19(6), pp. 791-799. (doi: 10.1111/dom.12877) (PMID:28093841)

Neisius, U., Olson, E., Rossi, S. H., Ibrahim, H. A., Currie, G. , Dominiczak, A. and Delles, C. (2017) Evaluation of the systemic micro- and macrovasculature in stable angina: a case-control study. PLoS ONE, 12(5), e0178412. (doi: 10.1371/journal.pone.0178412) (PMID:28542516) (PMCID:PMC5444845)

Currie, G. and Delles, C. (2017) The future of "omics" in hypertension. Canadian Journal of Cardiology, 33(5), pp. 601-610. (doi: 10.1016/j.cjca.2016.11.023) (PMID:28161100) (PMCID:5417769)

2016

Currie, G. and Delles, C. (2016) Urinary proteomics for diagnosis and monitoring of diabetic nephropathy. Current Diabetes Reports, 16(11), 104. (doi: 10.1007/s11892-016-0798-3) (PMID:27658932)

Currie, G. , Matt, P. and Delles, C. (2016) Clinical cardiovascular proteomics. In: Agnetti, G., Lindsey, M. L. and Foster, D. B. (eds.) Manual of Cardiovascular Proteomics. Springer, pp. 389-414. ISBN 9783319318264 (doi: 10.1007/978-3-319-31828-8_17)

Currie, G. et al. (2016) Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrology, 17, 127. (doi: 10.1186/s12882-016-0337-0) (PMID:27609359) (PMCID:PMC5015203)

Currie, G. and Delles, C. (2016) Use of biomarkers in the evaluation and treatment of hypertensive patients. Current Hypertension Reports, 18(7), 54. (doi: 10.1007/s11906-016-0661-6) (PMID:27221728)

Eisele, N. et al. (2016) Placental expression of the angiogenic placental growth factor is stimulated by both aldosterone and simulated starvation. Placenta, 40, pp. 18-24. (doi: 10.1016/j.placenta.2016.02.004) (PMID:27016778)

Currie, G. , Delles, C. , Touyz, R. M. , Staessen, J. A., Dominiczak, A. F. , Jennings, G. L. R. and Wang, J.-G. (2016) A woman with treatment-resistant hypertension. Hypertension, 67(2), pp. 243-250. (doi: 10.1161/HYPERTENSIONAHA.115.06756) (PMID:26711735)

Small, H. Y., Currie, G. E. and Delles, C. (2016) Prostasin, proteases, and preeclampsia. Journal of Hypertension, 34(2), pp. 193-195. (doi: 10.1097/hjh.0000000000000828) (PMID:26682786)

Lindhardt, M. et al. (2016) Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial. BMJ Open, 6(3), e010310. (doi: 10.1136/bmjopen-2015-010310) (PMID:26936907) (PMCID:PMC4785328)

Sheikh, A. M., Small, H. Y., Currie, G. and Delles, C. (2016) Systematic review of micro-RNA expression in pre-eclampsia identifies a number of common pathways associated with the disease. PLoS ONE, 11(8), e0160808. (doi: 10.1371/journal.pone.0160808) (PMID:27529341) (PMCID:PMC4986940)

2015

Currie, G. , Carty, D. M., Connell, J. M. and Freel, M. (2015) Endocrine aspects of pre-eclampsia. Cardiovascular Endocrinology, 4(1), pp. 1-10. (doi: 10.1097/XCE.0000000000000039)

Mistry, H.D., Eisele, N., Escher, G., Dick, B., Surbek, D., Delles, C. , Currie, G. , Schlembach, D., Mohaupt, M.G. and Gennari-Moser, C. (2015) Gestation-specific reference intervals for comprehensive spot urinary steroid hormone metabolite analysis in normal singleton pregnancy and 6 weeks postpartum. Reproductive Biology and Endocrinology, 13, 101. (doi: 10.1186/s12958-015-0100-6) (PMID:26337185) (PMCID:PMC4559160)

2014

Currie, G. , McKay, G. and Delles, C. (2014) Biomarkers in diabetic nephropathy: present and future. World Journal of Diabetes, 5(6), pp. 763-776. 25512779. (doi: 10.4239/wjd.v5.i6.763) (PMID:PMC4265863)

2013

Currie, G. , Sidhu, H., Fisher, M. and McKay, G. (2013) Losartan. Practical Diabetes, 30(2), pp. 91-93. (doi: 10.1002/pdi.1751)

Currie, G. and Delles, C. (2013) Proteinuria and its relation to cardiovascular disease. International Journal of Nephrology and Renovascular Disease, 7, pp. 13-24. (doi: 10.2147/IJNRD.S40522) (PMID:24379690) (PMCID:PMC3873205)

2012

Currie, G. , Freel, E. M., Perry, C. G. and Dominiczak, A. F. (2012) Disorders of blood pressure regulation — role of catecholamine biosynthesis, release, and metabolism. Current Hypertension Reports, 14(1), pp. 38-45. (doi: 10.1007/s11906-011-0239-2)

This list was generated on Wed Oct 30 21:24:02 2024 GMT.
Number of items: 35.

Articles

Rotbain Curovic, V. et al. (2023) Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – a post-hoc analysis of the PRIORITY randomized clinical trial. Journal of Diabetes and its Complications, 37(4), 108433. (doi: 10.1016/j.jdiacomp.2023.108433) (PMID:36841085)

Connelly, P. J. , Currie, G. and Delles, C. (2022) Sex differences in the prevalence, outcomes and management of hypertension. Current Hypertension Reports, 24(6), pp. 185-192. (doi: 10.1007/s11906-022-01183-8) (PMID:35254589) (PMCID:PMC9239955)

Currie, G. , Mary, S. and Delles, C. (2020) Is there a role for proteomics in diabetic renal disease? NDT Plus, 35(7), pp. 1133-1135. (doi: 10.1093/ndt/gfz017) (PMID:32777079) (PMCID:PMC7417003)

Tofte, N. et al. (2020) Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial. Lancet Diabetes and Endocrinology, 8(4), pp. 301-312. (doi: 10.1016/S2213-8587(20)30026-7) (PMID:32135136)

Connelly, P. J. , Freel, E. M., Perry, C., Ewan, J., Touyz, R. M. , Currie, G. and Delles, C. (2019) Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults. Hypertension, 74(6), pp. 1266-1274. (doi: 10.1161/HYPERTENSIONAHA.119.13080) (PMID:31656099) (PMCID:PMC6887638)

Currie, G. and Delles, C. (2019) Vascular biomedicine in an era of chronic disease and multimorbidity. Clinical Science, 133(9), pp. 1137-1143. (doi: 10.1042/CS20180764) (PMID:31088896) (PMCID:PMC6522703)

Tofte, N. et al. (2018) Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes. Diabetic Medicine, 35(10), pp. 1375-1382. (doi: 10.1111/dme.13669) (PMID:29781558)

Siméon, S., Massy, Z., Højlund, K., Lalic, K., Porcellati, F., Dekker, J., Petrie, J. , Currie, G. and Balkau, B. (2018) Renal function markers and insulin sensitivity after 3 years in a healthy cohort, the EGIR-RISC study. BMC Nephrology, 19, 124. (doi: 10.1186/s12882-018-0918-1) (PMID:29855339) (PMCID:PMC5984396)

Currie, G. E. et al. (2018) Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria. Cardiovascular Diabetology, 17, 50. (doi: 10.1186/s12933-018-0697-9) (PMID:29625564) (PMCID:PMC5889591)

Delles, C. and Currie, G. (2018) Sex differences in hypertension and other cardiovascular diseases. Journal of Hypertension, 36(4), pp. 768-770. (doi: 10.1097/HJH.0000000000001655) (PMID:29489615) (PMCID:PMCID: PMC5856361)

Currie, G. and Delles, C. (2018) Blood pressure targets in the elderly. Journal of Hypertension, 36(2), pp. 234-236. (doi: 10.1097/HJH.0000000000001576)

Currie, G. and Delles, C. (2017) Healthy vascular ageing. Hypertension, 70(2), pp. 229-231. (doi: 10.1161/HYPERTENSIONAHA.117.09122) (PMID:28559393)

Currie, G. , Bethel, M. A., Holzhauer, B., Haffner, S. M., Holman, R. R. and McMurray, J. J.V. (2017) Effect of valsartan on kidney outcomes in people with impaired glucose tolerance. Diabetes, Obesity and Metabolism, 19(6), pp. 791-799. (doi: 10.1111/dom.12877) (PMID:28093841)

Neisius, U., Olson, E., Rossi, S. H., Ibrahim, H. A., Currie, G. , Dominiczak, A. and Delles, C. (2017) Evaluation of the systemic micro- and macrovasculature in stable angina: a case-control study. PLoS ONE, 12(5), e0178412. (doi: 10.1371/journal.pone.0178412) (PMID:28542516) (PMCID:PMC5444845)

Currie, G. and Delles, C. (2017) The future of "omics" in hypertension. Canadian Journal of Cardiology, 33(5), pp. 601-610. (doi: 10.1016/j.cjca.2016.11.023) (PMID:28161100) (PMCID:5417769)

Currie, G. and Delles, C. (2016) Urinary proteomics for diagnosis and monitoring of diabetic nephropathy. Current Diabetes Reports, 16(11), 104. (doi: 10.1007/s11892-016-0798-3) (PMID:27658932)

Currie, G. et al. (2016) Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrology, 17, 127. (doi: 10.1186/s12882-016-0337-0) (PMID:27609359) (PMCID:PMC5015203)

Currie, G. and Delles, C. (2016) Use of biomarkers in the evaluation and treatment of hypertensive patients. Current Hypertension Reports, 18(7), 54. (doi: 10.1007/s11906-016-0661-6) (PMID:27221728)

Eisele, N. et al. (2016) Placental expression of the angiogenic placental growth factor is stimulated by both aldosterone and simulated starvation. Placenta, 40, pp. 18-24. (doi: 10.1016/j.placenta.2016.02.004) (PMID:27016778)

Currie, G. , Delles, C. , Touyz, R. M. , Staessen, J. A., Dominiczak, A. F. , Jennings, G. L. R. and Wang, J.-G. (2016) A woman with treatment-resistant hypertension. Hypertension, 67(2), pp. 243-250. (doi: 10.1161/HYPERTENSIONAHA.115.06756) (PMID:26711735)

Small, H. Y., Currie, G. E. and Delles, C. (2016) Prostasin, proteases, and preeclampsia. Journal of Hypertension, 34(2), pp. 193-195. (doi: 10.1097/hjh.0000000000000828) (PMID:26682786)

Lindhardt, M. et al. (2016) Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial. BMJ Open, 6(3), e010310. (doi: 10.1136/bmjopen-2015-010310) (PMID:26936907) (PMCID:PMC4785328)

Sheikh, A. M., Small, H. Y., Currie, G. and Delles, C. (2016) Systematic review of micro-RNA expression in pre-eclampsia identifies a number of common pathways associated with the disease. PLoS ONE, 11(8), e0160808. (doi: 10.1371/journal.pone.0160808) (PMID:27529341) (PMCID:PMC4986940)

Currie, G. , Carty, D. M., Connell, J. M. and Freel, M. (2015) Endocrine aspects of pre-eclampsia. Cardiovascular Endocrinology, 4(1), pp. 1-10. (doi: 10.1097/XCE.0000000000000039)

Mistry, H.D., Eisele, N., Escher, G., Dick, B., Surbek, D., Delles, C. , Currie, G. , Schlembach, D., Mohaupt, M.G. and Gennari-Moser, C. (2015) Gestation-specific reference intervals for comprehensive spot urinary steroid hormone metabolite analysis in normal singleton pregnancy and 6 weeks postpartum. Reproductive Biology and Endocrinology, 13, 101. (doi: 10.1186/s12958-015-0100-6) (PMID:26337185) (PMCID:PMC4559160)

Currie, G. , McKay, G. and Delles, C. (2014) Biomarkers in diabetic nephropathy: present and future. World Journal of Diabetes, 5(6), pp. 763-776. 25512779. (doi: 10.4239/wjd.v5.i6.763) (PMID:PMC4265863)

Currie, G. , Sidhu, H., Fisher, M. and McKay, G. (2013) Losartan. Practical Diabetes, 30(2), pp. 91-93. (doi: 10.1002/pdi.1751)

Currie, G. and Delles, C. (2013) Proteinuria and its relation to cardiovascular disease. International Journal of Nephrology and Renovascular Disease, 7, pp. 13-24. (doi: 10.2147/IJNRD.S40522) (PMID:24379690) (PMCID:PMC3873205)

Currie, G. , Freel, E. M., Perry, C. G. and Dominiczak, A. F. (2012) Disorders of blood pressure regulation — role of catecholamine biosynthesis, release, and metabolism. Current Hypertension Reports, 14(1), pp. 38-45. (doi: 10.1007/s11906-011-0239-2)

Book Sections

Mary, S. , Currie, G. , Schutte, A. E. and Delles, C. (2020) Cardiovascular proteomics. In: Faintuch, J. and Faintuch, S. (eds.) Precision Medicine for Investigators, Practitioners and Providers. Academic Press: London ; San Diego, CA, pp. 263-270. ISBN 9780128191781 (doi: 10.1016/b978-0-12-819178-1.00025-3)

Currie, G. and Nilsson, P. M. (2019) Healthy vascular ageing and early vascular ageing. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 307-318. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_29)

Ravassa, S., Delles, C. , Currie, G. and Díez, J. (2019) Biomarkers of cardiovascular disease. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 319-330. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_30)

Small, H. Y., Currie, G. and Delles, C. (2019) Endothelial dysfunction. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 183-192. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_17)

Currie, G. , Matt, P. and Delles, C. (2016) Clinical cardiovascular proteomics. In: Agnetti, G., Lindsey, M. L. and Foster, D. B. (eds.) Manual of Cardiovascular Proteomics. Springer, pp. 389-414. ISBN 9783319318264 (doi: 10.1007/978-3-319-31828-8_17)

Conference or Workshop Item

Setjiadi, D., Delles, C. , Currie, G. and Celis-Morales, C. A. (2023) Relationship between blood pressure level and hypertensive mediated organ damage. The 26th Annual Meeting of the Scottish Cardiovascular Forum, Aberdeen, UK, 04 Feb 2023. A2.1-A2. (doi: 10.1136/heartjnl-SCF-2023.4)

This list was generated on Wed Oct 30 21:24:02 2024 GMT.